GGrantIndex
Sort

64,565 grants matching drug discovery

SBIR Phase II: Information Extraction from Synthetic Procedures

$781,919
Paul Van Eikeren · Intellichem Inc. · · FY2001 · TIP

Robust Accurate Identification of peptides from tandem mass spectrometry data

$781,713
Yi-Kuo Yu · National Library Of Medicine · ZIA · FY2017 · LM

Ikaros family genes and lupus susceptibility across ethnically diverse populations

$781,667
Swapan K Nath · Oklahoma Medical Research Foundation · R01 · FY2021 · AI

Ikaros family genes and lupus susceptibility across ethnically diverse populations

$781,667
Swapan K Nath · Oklahoma Medical Research Foundation · R01 · FY2020 · AI

NMR Studies of Retroviral Nucleic Acid Binding Proteins

$781,610
Michael F. Summers · University Of Maryland Baltimore County · R01 · FY2023 · AI

Finding combinatorial drug repositioning therapy for Alzheimer's disease and related dementias

$781,522
Xiaoqian Jiang · University Of Texas Hlth Sci Ctr Houston · R01 · FY2020 · AG

Detecting synergistic effects of pharmacological and non-pharmacological interventions for AD/ADRD

$781,522
Rui Zhang · University Of Minnesota · R01 · FY2022 · AG

A novel platform for nonribosomal peptide discovery

$781,502
Bahar Behsaz · Chemia Biosciences, Inc. · R44 · FY2025 · GM

Genetics of Elevated High Density Lipoprotein Cholesterol

$781,434
Daniel James Rader · University Of Pennsylvania · R01 · FY2012 · HL

Genetics of Elevated High Density Lipoprotein Cholesterol

$781,429
Daniel James Rader · University Of Pennsylvania · R01 · FY2011 · HL

TREM2 Genotype-Informed Drug Repurposing and Combination Therapy Design for Alzheimer’s Disease

$781,379
Feixiong Cheng · Cleveland Clinic Lerner Com-Cwru · R01 · FY2025 · AG

Mechanisms of Prion Protein Toxicity

$781,315
David A Harris · Boston University Medical Campus · R01 · FY2024 · NS

Novel Drug Discovery against P. falciparum ENR

$781,198
James C Sacchettini · Texas A&M Agrilife Research · P01 · FY2006 · AI

Identification and validation of targets for therapeutic intervention in rare diseases of intermediary metabolism

$781,186
Brian Robert Wamhoff · Hemoshear Therapeutics, Llc · R44 · FY2017 · TR

Multimodal biocompatible microLED devices for diverse neuroscience applications

$781,178
Robert W Gereau · Washington University · R01 · FY2015 · NS

Deciphering the role of ddhCTP in viperin-related functions

$781,139
Tyler L Grove · Albert Einstein College Of Medicine · R01 · FY2024 · AI

Single-cell based diagnostic platform with single-molecular transcriptional response profiling for rapid phenotypic antimicrobial susceptibility testing of gonorrhea

$781,097
Tza-Huei Jeff Wang · Johns Hopkins University · R01 · FY2025 · AI

Subtype-selective NMDA ligands for Alzheimer's Disease

$780,998
Steven H Liang · Emory University · R01 · FY2023 · AG

Clinical and Translational Science Award

$780,994
Robert Stanley Sherwin · Yale University · KL2 · FY2010 · RR

Frontotemporal dementia and related disorders: transcriptomic profiling, biomarker discovery, and mechanistic insight

$780,935
Marka Van Blitterswijk · Mayo Clinic Jacksonville · R01 · FY2023 · NS

Frontotemporal dementia and related disorders: transcriptomic profiling, biomarker discovery, and mechanistic insight

$780,935
Marka Van Blitterswijk · Mayo Clinic Jacksonville · R01 · FY2022 · NS

Frontotemporal dementia and related disorders: transcriptomic profiling, biomarker discovery, and mechanistic insight

$780,935
Marka Van Blitterswijk · Mayo Clinic Jacksonville · R01 · FY2025 · NS

Frontotemporal dementia and related disorders: transcriptomic profiling, biomarker discovery, and mechanistic insight

$780,935
Marka Van Blitterswijk · Mayo Clinic Jacksonville · R01 · FY2021 · NS

Frontotemporal dementia and related disorders: transcriptomic profiling, biomarker discovery, and mechanistic insight

$780,935
Marka Van Blitterswijk · Mayo Clinic Jacksonville · R01 · FY2024 · NS

Polymerase Inhibitors of Respiratory Syncytial Virus

$780,845
Richard K. Plemper · Georgia State University · R01 · FY2021 · AI